Manning & Napier Group, LLC Novartis Ag Transaction History

Manning & Napier Group, LLC

$8.76 Billion
Q1 2024

A detailed history of Manning & Napier Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Manning & Napier Group, LLC holds 1,042,426 shares of NVS stock, worth $116 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

1,042,426

Previous 1,057,168 1.39%

Holding current value

$116 Million

Previous $107 Million 5.54%

% of portfolio

1.15%

Previous 1.27%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$95.27 - $108.47 $1.4 Million - $1.6 Million	-14,742 Reduced 1.39%	1,042,426 $101 Million
Q4 2023 Jan 19, 2024	SELL	$92.27 - $101.54 $1.11 Million - $1.22 Million	-12,025 Reduced 1.12%	1,057,168 $107 Million
Q3 2023 Oct 20, 2023	SELL	$94.73 - $105.13 $1.58 Million - $1.75 Million	-16,638 Reduced 1.53%	1,069,193 $109 Million
Q2 2023 Jul 26, 2023	SELL	$92.52 - $104.91 $62.3 Million - $70.7 Million	-673,799 Reduced 38.29%	1,085,831 $110 Million
Q1 2023 Apr 17, 2023	BUY	$80.03 - $92.81 $122,525 - $142,092	1,531 Added 0.09%	1,759,630 $162 Million
Q4 2022 Jan 26, 2023	SELL	$75.55 - $92.52 $2.46 Million - $3.02 Million	-32,591 Reduced 1.82%	1,758,099 $0
Q3 2022 Oct 18, 2022	SELL	$74.61 - $87.26 $913,450 - $1.07 Million	-12,243 Reduced 0.68%	1,790,690 $136 Million
Q2 2022 Jul 12, 2022	SELL	$80.52 - $93.75 $2.66 Million - $3.1 Million	-33,047 Reduced 1.8%	1,802,933 $152 Million
Q1 2022 Apr 19, 2022	SELL	$80.11 - $90.62 $7.39 Million - $8.36 Million	-92,246 Reduced 4.78%	1,835,980 $161 Million
Q4 2021 Jan 27, 2022	BUY	$79.7 - $88.13 $1.45 Million - $1.61 Million	18,232 Added 0.95%	1,928,226 $169 Million
Q3 2021 Oct 14, 2021	BUY	$81.78 - $95.14 $2.1 Million - $2.44 Million	25,665 Added 1.36%	1,909,994 $156 Million
Q2 2021 Jul 19, 2021	BUY	$85.24 - $94.15 $13.1 Million - $14.5 Million	153,982 Added 8.9%	1,884,329 $172 Million
Q1 2021 Apr 28, 2021	SELL	$83.5 - $98.47 $34.1 Million - $40.2 Million	-407,958 Reduced 19.08%	1,730,347 $148 Million
Q4 2020 Jan 20, 2021	SELL	$78.07 - $94.43 $4.06 Million - $4.92 Million	-52,060 Reduced 2.38%	2,138,305 $202 Million
Q3 2020 Oct 29, 2020	BUY	$82.14 - $91.0 $5.11 Million - $5.66 Million	62,239 Added 2.92%	2,190,365 $190 Million
Q2 2020 Jul 10, 2020	SELL	$80.93 - $91.1 $7.32 Million - $8.25 Million	-90,509 Reduced 4.08%	2,128,126 $186 Million
Q1 2020 Apr 13, 2020	BUY	$70.67 - $99.01 $4.16 Million - $5.83 Million	58,901 Added 2.73%	2,218,635 $183 Million
Q4 2019 Jan 10, 2020	SELL	$84.35 - $95.37 $21.4 Million - $24.2 Million	-253,817 Reduced 10.52%	2,159,734 $205 Million
Q3 2019 Oct 10, 2019	SELL	$85.54 - $94.26 $7.3 Million - $8.05 Million	-85,376 Reduced 3.42%	2,413,551 $210 Million
Q2 2019 Jul 24, 2019	SELL	$75.4 - $92.8 $57.6 Million - $70.9 Million	-764,533 Reduced 23.43%	2,498,927 $228 Million
Q1 2019 Apr 10, 2019	SELL	$75.32 - $86.15 $11.4 Million - $13.1 Million	-151,747 Reduced 4.44%	3,263,460 $314 Million
Q4 2018 Jan 24, 2019	SELL	$73.66 - $82.02 $5.21 Million - $5.81 Million	-70,797 Reduced 2.03%	3,415,207 $293 Million
Q3 2018 Oct 10, 2018	SELL	$66.94 - $77.43 $13.1 Million - $15.2 Million	-196,031 Reduced 5.32%	3,486,004 $300 Million
Q2 2018 Jul 13, 2018	SELL	$64.91 - $73.36 $4.78 Million - $5.4 Million	-73,628 Reduced 1.96%	3,682,035 $278 Million
Q1 2018 May 01, 2018	SELL	$70.39 - $84.15 $11.6 Million - $13.9 Million	-165,254 Reduced 4.21%	3,755,663 $304 Million
Q4 2017 Feb 05, 2018	BUY	$72.33 - $77.64 $284 Million - $304 Million	3,920,917	3,920,917 $329 Million

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Account

Manning & Napier Group, LLC Novartis Ag Transaction History